Growth Factors and Cytokines in Uterine Leiomyomas

Seminars in Reproductive Endocrinology

Volumn 14, Issue 3, 1996, Pages 269-282

  Andersen, Janet ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Growth factors; Leiomyomas; Myometrium

Indexed keywords

CONNEXIN 43; CYTOKINE; ESTROGEN; GESTAGEN; GROWTH PROMOTOR; PROGESTERONE;

ADULT; CHROMOSOME ABERRATION; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; FEMALE; GENETICS; HUMAN; LEIOMYOMA; MENSTRUAL CYCLE; METABOLISM; MIDDLE AGED; MYOMETRIUM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; UTERUS CANCER;

ADULT; CHROMOSOME ABERRATIONS; CONNEXIN 43; CYTOKINES; ESTROGENS; FEMALE; GROWTH SUBSTANCES; HUMANS; LEIOMYOMA; MENSTRUAL CYCLE; MIDDLE AGED; MYOMETRIUM; PROGESTERONE; PROGESTINS; UTERINE NEOPLASMS;

EID: 0030203887     PISSN: 07348630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1016336     Document Type: Article

References (123)

1. Weinberg RA: Growth factors and oncogenes. In Weinberg RA (ed): Oncogenes and the Molecular Origins of Cancer. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
2. Levine AJ: The tumor suppressor genes. Annu Rev Biochem 62:623-651, 1993
3. Fisher DE: Apoptosis in cancer therapy: Crossing the threshold. Cell 78:539-542, 1994
4. Furcht LT: Critical factors controlling angiogenesis: Cell products, cell matrix, and growth factors. Lab Invest 55:505-509, 1986
5. Gown AM, Boyd HC, Chang Y, Ferguson M, Reichler B, Tippens D: Smooth muscle cells can express cytokeratins of "simple" epithelium. Am J Pathol 132:223-232, 1988
6. Scully RE: Pathology of Leiomyomas. Semin Reproductive Endocrinology 10:325-331, 1992
7. Cramer SF, Patel A: The frequency of uterine leiomyomas. Am J Clin Pathol 94:435-438, 1990
8. Rotmensch J, Bosnyak S, Montag A: Malignant transition of uterine leiomyomata. Int J Gynecol Obstet 42:47-49, 1992
9. Townstend DE, Sparkes RS, Baluda MC, McClelland G: Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis of glucose-6-phosphate dehydrogenase. Am J Obstet Gynecol 107:1168-1173, 1970
10. Spiro RH, McPeak CJ: On the so-called metastasizing leiomyomas. Cancer 19:544-548, 1966
11. Gloudemans T, Pospiech I, Van Der ven LT, et al: Expression and CpG methylation of the insulin-like growth factor II gene in human smooth muscle tumors. Cancer Res 52:6516-6521, 1992
12. Vu TH, Yballe C, Boonyanit S, Hoffman AR: Insulin-like growth factor II in uterine smooth-muscle tumors: Maintenance of genomic imprinting in leiomyomata and loss of imprinting in leiomyosarcomata. J Clin Endocrinol Metab 80:1670-1676, 1995
13. Eyden BP, Hale RJ, Richmond I, Buckley CH: Cytoskeletal filaments in the smooth muscle cells of uterine leiomyomata and myometrium: An ultrastructural and immunohistochemical analysis. Virchows Arch Pathol Anat 420:51-58, 1992
14. Cavaillé F, Fournier E, Dallot C, Dhellemes C, Ferré FL: Myosin Heavy Chain Isoform Expression in Human Myometrium: Presence of an Embryonic Nonmuscle Isoform in Leiomyomas and in Cultured Cells. Cell Motil Cytoskel 30:183-193, 1995
15. Brandon DD, Bethers CL, Strawn ET, et al: Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas. Am J Obstet Gynecol 169:78-85, 1993
16. Andersen J, DyReyes V, Barbieri RL, Coachman D, Miksicek R: Leiomyoma primary cultures have elevated transcriptional response to estrogen compared to autologous myometrial cultures. J Soc Gynecol Invest 2:542-551, 1995
17. Brandon DD, Erickson TE, Keenan EJ, et al: Estrogen receptor gene expression in human uterine leiomyomata. J Clin Endocrinol 80:1876-1881, 1995
18. Zhao K, Kuperman L, Geimonen E, Andersen J: Progestin represses human connexin43 gene expression similarly in primary cultures of myometrial and uterine leiomyomas. Biol Reprod 54:607-615, 1996
19. Andersen J, Barbieri RL: Abnormal gene expression in uterine leiomyomas. J Soc Gynecol Invest 2:663-672, 1995
20. Pandis N, Heim S, Bardi G, et al: Chromosome analysis of 96 uterine leiomyomas. Cancer Genet Cytogenet 55:11-18, 1991
21. McKusick VA: Mendelian Inheritance in Man: Catalogs of Autosomal Recessive and X-Linked Phenotypes. 9th ed. Baltimore, The Johns Hopkins University Press, 1990
22. Rein MS, Barbieri RL, Friedman AJ: Progesterone: A critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol 172:14-18, 1995
23. Meloni AM, Surti U, Contento AM, Davare J, Sandberg AA: Uterine leiomyomas: Cytogenetic and histologic profile. Obstet Gynecol 80:209-217, 1992
24. Nibert M, Heim S: Uterine leiomyoma cytogenetics. Genes Chromosomes Cancer 2:3-13, 1990
25. Han K, Lee W, Harris CP, et al: Comparison of chromosome aberrations in leiomyoma and leiomyosarcoma using FISH on archival tissues. Cancer Genet Cytogenet 74:19-24, 1994
26. Cramer SF, Robertson AL, Ziats NP, Pearson OH: Growth potential of human uterine leiomyomas: Some in vitro observations and their implications. Obstet Gynecol 66:36-41, 1985
27. Kawaguchi K, Fujii S, Konishi I, Okamura H, Mori T: Ultrastructural study of cultured smooth muscle cells from uterine leiomyoma and myometrium under the influence of sex steroids. Gynecol Oncol 21:32-41, 1985
28. Kawaguchi K, Fujii S, Konishi I, Nanbu Y, Nonogake H, Mori T: Mitotic activity in uterine leiomyomas during the menstrual cycle. Am J Obstet Gynecol 160:637-641, 1989
29. Pastore GN, Dicola LP, Dollahon FR, Gardner RM: Effect of estriol on the structure and organization of collagen in the lamina propria of the immature rat uterus. Biol Reprod 47:83-91, 1992
30. Rein MS, Barbieri RL, Welch W, Gleason RE, Caulfield JP, Friedman AJ: The concentration of collagen-associated amino acids are higher in GnRH agonist-treated uterine myomas. Obstet Gynecol 82:901-905, 1993
31. Thorneycroft IH, Mishell DR Jr, Stone SC, Kharna KM, Nakamura RM: The relation of serum 17-hydroxyprogesterone and estradiol-17β levels during the human menstrual cycle. Am J Obstet Gynecol 111:947-951, 1971
32. Kempson RL, Hendrickson MR: Pure mesenchymal neoplasms of the uterine corpus: Selected problems. Semin Diagn Pathol 5:172-198, 1988
33. Tiltman A: The effect of progestins on the mitotic activity of uterine fibromyomas. Int J Gynecol Pathol 4:89-96, 1985
34. Smith SK: The regulation of fibroid growth: Time for a rethink? Br J Obstet Gynaecol 100:977-979, 1993
35. Lipschütz A: Experimental fibroids and the antifibromatogenic action of steroid hormones. J Am Med 120:171-175, 1942
36. Porter KB, Tsibris JCM, Nicosia SV, et al: Estrogen-induced guinea pig model for uterine leiomyomas: Do the ovaries protect? Biol Reprod 52:824-832, 1995
37. Howe SR, Gottardis MM, Everitt JI, Walker C: Estrogen stimulation and tamoxifen inhibition of leiomyoma cell growth in vitro and in vivo. Endocrinology 136:4996-5003, 1994
38. Maheux R: Treatment of uterine leiomyomata: Past, present and future. Horm Res 32:125-133, 1989
39. Benagiano G: Uterine fibroids: Literature review and summary of posters. Horm Res 32(suppl 1):120-124, 1989
40. Friedman AJ, Lobel SM, Rein MS, Barbieri RL: Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: The estrogen threshold hypothesis. Am J Obstet Gynecol 163:1114-1119, 1990
41. Stovall TG, Ling FW, Henry LC, Woodruff MR: A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas. Am J Obstet Gynecol 164:1420-1425, 1991
42. Lemay A, Surrey ES, Friedman AJ: Extending the use of gonadotropin-releasing hormone agonists: The emerging role of steroidal and non-steroidal agents. Fertil Steril 61:21-34, 1994
43. Friedman AJ, Daly M, Juneau-Norcross M, Gleason R, Rein MS, LeBoff M: Long-term medical therapy for leiomyomata uteri: A prospective, randomized study of leuprolide acetate depot plus either estrogen-progestin or progestin "add-back" for two years. Hum Reprod 9:1618-1625, 1994
44. Carr BR, Marshburn PB, Weatherall PT, et al: An evaluation of the effects of gonadotropin-releasing hormone analogues and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: A prospective, randomized, double blind, placebo-controlled, crossover trial. J Clin Endocrinol Metab 76:1217-1223, 1993
45. Murphy AA, Kettel ML, Morales AJ, Roberts VJ, Yen SSC: Regression of uterine leiomyomata in response to the antiprogesterone RU 486. J Clin Endocrinol 76:513-517, 1993
46. McDonnell DP: Unraveling the human progesterone receptor signal transduction pathway. Trends Endocrinol Metab 6:133-138, 1995
47. Read LD, Greene GL, Katzenellenbogen BS: Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors. Molec Endocrinol 3:295-304, 1989
48. Lessey BA, Killam AP, Metzger DA, Haney AF, Greene GL, McCarty KS: Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab 67:334-340, 1988
49. Rein MS, Friedman AJ, Stuart JM, MacLaughlin DT: Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate. Fertil Steril 53:1018-1023, 1990
50. Alexander IE, Clarke CL, Shine J, Sutherland RL: Progestin inhibition of progesterone receptor gene expression in human breast cancer cells. Molec Endocrinol 3:1377-1389, 1989
51. Vegeto E, Shahbaz MM, Wen DX, Goldman ME, O'Malley BW, McDonnell DP: Human progesterone receptor A form is a cell- and promoter-specific repressor of progesterone receptor B function. Molec Endocrinol 7:1244-1255, 1993
52. Fujimoto J, Ichigo S, Hori M, Nishigaki M, Tamaya T: Expression of progesterone receptor form A and B mRNAs in gynecologic malignant tumors. Tumor Biol 16:254-260, 1995
53. Kraus WL, Weis KE, Katzenellenbogen BS: Inhibitory crosstalk between steroid hormone receptors: Differential targeting of estrogen receptor in the repression of its transcriptional activity by agonist- and antagonist-occupied progestin receptors. Molec Cell Biol 15:1847-1857, 1995
54. Skerrett PJ: "Matrix algebra" heals life's wounds. Science 252:1064-1066, 1991
55. Skinner MK, Parrott JA: Growth factor-mediated cell-cell interactions in the ovary. In Findlay JK (ed): Molecular Biology of the Female Reproductive System. New York, Academic Press, 1994
56. Murphy LLJ, Ballejo G: Growth factor and cytokine expression in the endometrium. In Findlay JK (ed): Molecular Biology of the Female Reproductive System. New York, Academic Press, 1994
57. Gill GN: Growth factors and their receptors. In Weinberg RA (ed): Oncogenes and the Molecular Origins of Cancer. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
58. Colbert WE, Wilson BF, Williams PD, Williams GD: Relationship between in vitro relaxation of the costo-uterine smooth muscle and mesovarial leiomyoma formation in vivo by β-receptor agonist. Arch Toxicol 65:575-579, 1991
59. Gibson JP, Sells DM, Cheng HC, Yuh L: Induction of uterine leiomyomas in mice by medroxalol and prevention by propranolol. Toxicol Pathol 4:468-473, 1987
60. Avery Ince B, Montano MM, Katsenellenbogen BS: Activation of transcriptionally inactive human estrogen receptors by cyclic 3′,5′-monophosphate and ligands including antiestrogens. Molec Endocrinol 8:1397-1406, 1994
61. Sartorius CA, Groshong SD, Miller LA, et al: New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: Only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP. Cancer Res 54:3868-3877, 1994
62. Fayed YM, Tsibris JCM, Langenberg PW, Robertson AL: Human uterine leiomyoma cells: Binding and growth responses to epidermal growth factor, platelet-derived growth factor and insulin. Lab Invest 60:30-37, 1989
63. Yeh J, Rein M, Nowak R: Presence of messenger ribonucleic acid for epidermal growth factor (EGF) and EGF receptor demonstrable in monolayer cell cultures of myometria and leiomyomata. Fertil Steril 56:997-1000, 1991
64. DiAugustine RP, Petrusz P, Bell GI, et al: Influence of estrogens on mouse uterine epidermal growth factor precursor protein and messenger ribonucleic acid. Endocrinology 122:2355-2363, 1988
65. Huet-Hudson YM, Chakraborty C, De SK, Suzuki Y, Andrews GK, Dey SK: Estrogen regulates the synthesis of epidermal growth factor in mouse uterine epithelial cells. Molec Endocrinol 4:510-523, 1990
66. Harrison-Woolrych ML, Stephen D, Charnock-Jones DS, Smith SK: Quantification of messenger ribonucleic acid for epidermal growth factor in human myometrium and leiomyomata using reverse transcriptase polymerase chain reaction. J Clin Endocrinol Metab 78:1179-1184, 1994
67. Makku VR, Stancel GM: Regulation of epidermal growth factor receptor by estrogen. JBC 260:9820-9824, 1985
68. Musgrove EA, Lee CSL, Sutherland RL: Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor α, epidermal growth factor receptor, c-fos, and c-myc genes. Molec Cell Biol 11:5032-5043, 1991
69. Hofmann GE, Rao CV, Barrows GH, Schultz GS, Sanfilippo JS: Binding sites for epidermal growth factor in human uterine tissues and leiomyomas. J Clin Endocrinol Metab 58:880-884, 1984
70. 125I-epidermal growth factor in human uterus. Cell Tissue 246:543-548, 1986
71. Lumsden MA, West CP, Hawkins RA, Bramley TA, Rumgay L, Baird DT: The binding of epidermal growth factor to myometrium and leiomyomata in women rendered hypooestrogenic by continuous administration of an LHRH agonist. Br J Obstet Gynecol 95:1299-1304, 1988
72. Murphy LJ, Murphy LC, Friesen HG: Estrogen induces insulin-like growth factor-I expression in the rat uterus. Molec Endocrinol 1:445-450, 1987
73. Murphy LJ, Ghahary A: Uterine insulin-like growth factor-I: Regulation of expression and its role in estrogen-induced uterine proliferation. Endocrine Rev 11:443-452, 1990
74. Kapur S, Tamada H, Dey SK, Andrews GK: Expression of insulin-like growth factor-1 (IGF-1) and its receptor in the peri-implantation mouse uterus, and cell-specific regulations of IGF-1 gene expression by estradiol and progesterone. Biol Reprod 46:208-219, 1992
75. Norstedt G, Levinovitz A, Eriksson H: Regulation of uterine insulin-like growth factor I mRNA and insulin-like growth factor II mRNA by estrogen in the rat. Acta Endocrinol 120:466-472, 1989
76. Höppener JWM, Mosselman S, Roholl PJM, et al: Expression of insulin-like growth factor-I and II genes in human smooth muscle tumors. EMBO J 7:1379-1385, 1988
77. Boehm KD, Daimon M, Gorodeski IF, Sheean LA, Utian WH, Ilan J: Expression of the insulin-like and platelet-derived growth factor genes in human uterine tissues. Molec Reprod Dev 27:93-101, 1990
78. Vollenhoven BJ, Herrington AC, Healy DL: Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium. J Clin Endocrinol Metab 76:1106-1110, 1993
79. Rein MS, Friedman AJ, Pandian MR, Heffner LJ: The secretion of insulin-like growth factors I and II by explant cultures of fibroids and myometrium from women treated with a gonadotropin-releasing hormone agonist. Obstet Gynecol 76:388-394, 1990
80. Giudice LC, Irwin JC, Dsupin BA, et al: Insulin-like growth factor (IGF), IGF binding protein (IGFBP), and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata. Hum Reprod 8:1796-1806, 1993
81. Chandrasekhar Y, Heiner J, Osuamkpe C, Nagamani M: Insulin-like growth factor I and II binding in human myometrium and leiomyomas. Am J Obstet Gynecol 166:64-69, 1992
82. Erickson GF, Nakatanl A, Liu X-J, Shimasaki S, Ling N: Role of insulin-like growth factors (IGF) and IGF-binding proteins in folliculogenesis. In Findlay JK (ed): Molecular Biology of the Female Reproductive System. New York, Academic Press, 1994
83. Strawn EY, Novy MJ, Burry KA, Bethea CL: Insulin-like growth factor I promotes leiomyoma cell growth in vitro. Am J Obstet Gynecol 172:1837-1844, 1995
84. Lewis UJ, Singh NP, Seavey BK: Human prolactin isolation and some properties. Biochem Biophys Res Commun 44:1169-1176, 1971
85. Maslar IA, Riddick DH: Prolactin production by human endometrium during the normal menstrual cycle. Am J Obstet Gynecol 135:751-754, 1979
86. Frame LT, Rogol AD, Riddick DH, Baczynski E: Gel chromatography properties of human prolactin released from decidua tissue in vitro. Fertil Steril 31:647-650, 1979
87. Stewart EA, Jain P, Penglase MD, Friedman AJ, Nowak RA: The myometrium of postmenopausal women produces prolactin in response to human chorionic gonadotropin and α-subunit in vitro. Fertil Steril 64:972-976, 1995
88. Daly DC, Walters CA, Prior JC, et al: Prolactin production from proliferative phase leiomyoma. Am J Obstet Gynecol 148:1059-1063, 1984
89. Rein MS, Friedman AJ, Heffner LJ: Decreased prolactin secretion by explant cultures of fibroids from women treated with a gonadotropin-releasing hormone agonist. J Clin Endocrinol 70:1554-1558, 1990
90. Miura S, Koide SS: Effect of insulin and growth hormone on rat uterine RNA synthesis. Proc Soc Exp Biol Med 133:882-885, 1970
91. Grattarola R, Li C: Effect of growth hormone and its combination with estradiol-17 βon the uterus of hypophysectomized-ovariectomized rats. Endocrinology 65:802-810, 1959
92. Pezecny I, Bartova J, Skarda J: Growth hormone treatment increases oestrogen receptor concentration in the guinea pig uterus. J Endocrinol 134:5-9, 1992
93. Sharara FI, Nieman LK: Growth hormone receptor messenger ribonucleic acid expression in leiomyoma and surrounding myometrium. Am J Obstet Gynecol 172:814-819, 1995
94. Bryant-Greenwood GD: The human relaxins: Consensus and dissent. Molec Cell Endocrinol 79:C125-C132, 1991
95. Weiss G: The physiology of human relaxin. In Mancuso S (ed): Achievements in Gynecology. 1989-90 Contributions in Gynecology and Obstetrics. Vol. 18. Basel, Switzerland, 1991
96. Sanborn BM, Kuo KS, Weisbrodt Sherwood OD: The interaction of relaxin with the rat uterus: I. Effect on cyclic nucleotide levels and spontaneous contractions. Endocrinology 106:1210-1215, 1980
97. Kramer SM, Gibson UEM, Fendly BM, Mohler MA, Drolet DW, Johnston PD: Increase in cyclic AMP levels by relaxin in newborn rhesus monkey uterus cell culture. In Vitro Cell Dev Biol 26:647-656, 1990
98. Johnson MR, Jauniaux E, Jurkovic D, Sannino P, Campbell S, Nicolaides KH: Relaxin concentrations in exoembryonic fluids during the first trimester. Hum Reprod 9:1561-1562, 1994
99. Bongers-Binder S, Burgardt A, Seeger H, Voelter W, Lippert TH: Distribution of immunoreactive relaxin in the genital tract and in the mammary gland of non-pregnant women. Clin Exp Obst Gynecol XVIII:161-164, 1991
100. Sournia A, Koutsilieris M: Purification and partial sequencing of the major mitogen for human uterine smooth muscle-like cells in leiomyoma extracts. J Clin Invest 96:751-758, 1995
101. Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B: Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 105:1039-1045, 1987
102. Sporn MB, Roberts AB, Wakefield LM, Assoian RK: Transforming growth factor-β: Biological function and chemical structure. Science 233:532-534, 1986
103. Massagué J: Receptors for the TGF-β family. Cell 69:1067-1070, 1992
104. Beck CA, Garner CW: Stimulation of DNA synthesis in rat uterine cells by growth factors and uterine extracts. Molec Cell Endocrinol 84:109-118, 1992
105. Rotello RJ, Lieberman RC, Purchio AF, Gerschenson LE: Coordinated regulation of apoptosis and cell proliferation by transforming growth factor beta 1 in cultured uterine epithelial cells. Proc Natl Acad Sci 88:3412-3415, 1991
106. Das SK, Flanders KC, Andrews GK: Expression of transforming growth factor-beta isoforms (beta 2 and beta 3) in the mouse uterus: Analysis of the periimplantation period and effects of ovarian steroids. Endocrinology 130:3456-3466, 1992
107. Das SK, Paria BC, Andrews GK, Dey SK: Effects of 9-enetetrahydrocannabinol on expression of beta-type transforming growth factors, insulin-like growth factor-I and c-myc genes in the mouse uterus. J Steroid Biochem Molec Biol 45:459-465, 1993
108. Takahashi T, Eitzman B, Bossert NL, et al: Transforming growth factor beta 1, beta 2 and beta 3 messenger RNA and protein expression in mouse uterus and vagina during estrogen-induced growth: A comparison to other estrogen-regulated genes. Cell Growth Different 5:919-935, 1994
109. 125I] TGF beta 1-binding sites. Endocrinology 135:439-449, 1994
110. Mirza MR: Anti-estrogen induced synthesis of transforming growth factor-beta in breast cancer patients. Cancer Treatment Rev 18:145-148, 1991
111. Knabbe C, Lippman ME, Wakefield LM, et al: Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48:417-428, 1987
112. Roberts AB, Sporn MB, Assoian RK, et al: Transforming growth factor type β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci 83:4167-4171, 1986
113. Casey H, Mibe M, MacDonald PC: Transforming growth factor-beta 1 stimulation of parathyroid hormone-related protein expression in human uterine cells in culture: mRNA levels and protein secretion. J Clin Endocrinol Metab 74:950-952, 1992
114. Casey H, Mibe M, MacDonald PC: Regulation of parathyroid hormone-related protein gene expression in human endometrial stromal cells in culture. J Clin Endocrinol Metab 77:188-194, 1993
115. Ikeda K, Weir ED, Dannies PS, et al: Expression of messenger RNAs encoding a parathyroid hormone-like peptide in normal human and animal tissues with abnormal expression in human parathyroid adenomas. Molec Endocrinol 2:1230-1236, 1988
116. Ferguson JE, Gorman JV, Bruns DE, et al: Abundant expression of parathyroid hormone-related protein in human amnion and its association with labor. Proc Natl Acad Sci 89:8384-8388, 1992
117. Yasuda T, Banville D, Rabbani SA, Hendy GN, Goltzman D: Rat parathyroid hormone-like peptide: Comparison with the human homologue and expression in malignant and normal tissue. Molec Endocrinol 3:518-525, 1989
118. Thiede MA, Daifotis AG, Weir EC, et al: Intrauterine occupancy controls expression of the parathyroid hormone-related peptide gene in preterm rat myometrium. Proc Natl Acad Sci USA 87:6969-6973, 1990
119. Thiede M, Harm S, Hasson D, Gardner R: In vivo regulation of parathyroid hormone-related peptide messenger ribonucleic acid in the rat uterus by 17B-estradiol. Endocrinology 128:2317-2323, 1991
120. Weir EC, Goad DI, Daifotis AG, Burtis WJ, Dreyer BE, Nowak RA: Relative overexpression of the parathyroid hormone-related peptide gene in human leiomyomas. Clin Endocrinol Metabol 78:784-789, 1994
121. Ignotz RA, Massague J: Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261:4337-4345, 1986
122. Fujita M: Histological and biochemical studies of collagen in human uterine leiomyomas. Hokkaido Igaku Zasshi 60:602-615, 1985
123. Stewart A, Friedman AJ, Peck K, Nowak R: Relative overexpression of collagen type I and collagen type III mRNAs by uterine leiomyomas during the proliferative phase of the menstrual cycle. J Clin Endocrinol Metab 79:900-906, 1994